CANIGEN PUPPY 2b Suspension for injection
CANIGEN PUPPY 2b Suspension for injection
Authorised
- Canine parvovirus, strain CPV 39, Live
Product identification
Medicine name:
CANIGEN PUPPY 2b Suspension for injection
Canigen Puppy 2B
Active substance:
- Canine parvovirus, strain CPV 39, Live
Target species:
-
Dog
-
Dog (puppy)
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parvovirus, strain CPV 39, Live398107.00/50% tissue culture infectious dose1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Portugal
Available in:
-
Portugal
Package description:
- (ID2) 50 millilitre(s): Box (Cardboard) with 50 Bottle (Glass) each with 1 millilitre(s)
- (ID1) 10 millilitre(s): Box (Cardboard) with 10 Bottle (Glass) each with 1 millilitre(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- R743/05 DGV
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0230/001
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Hungary
-
Italy
-
Luxembourg
-
Netherlands
-
Portugal
-
Slovakia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 9/01/2025
